About BPC-157 Repair & Healing Peptide

BPC-157 is a peptide derived from gastric juice that research has indicated accelerates healing across tendons, ligaments, muscles, and the gut lining by promoting new blood vessel growth and reducing inflammation. While it is powerful on its own, you generally get faster, more comprehensive results from the GLOW combo (BPC-157 + TB-500 + GHK-Cu) for full-spectrum tissue and collagen repair or the KLOW combo if healing gut issues is your main priority.

Here is what the research (led extensively by Dr. Predrag Sikiri's lab at the University of Zagreb) shows:
* Accelerated Angiogenesis (New Blood Vessels): One of its core mechanisms is upregulating Vascular Endothelial Growth Factor (VEGF). By building new micro-vessels, it brings oxygen and blood flow to tissues that normally heal very slowly due to poor vascularity especially tendons, ligaments, and cartilage.
* Tendon, Muscle & Ligament Healing: In dozens of preclinical animal studies, BPC-157 significantly accelerated the repair of transected Achilles tendons, quadriceps tears, and ligament ruptures. It promotes fibroblast outgrowth, collagen synthesis, and tendon-to-bone integration.
* Gut Protection & Repair: Because of its gastric origin, research shows profound gastroprotective effects. It heals stomach ulcers, counteracts damage from NSAIDs (like ibuprofen), improves gut barrier integrity (tight junctions), and reduces inflammation in models of colitis and IBD.
* Nitric Oxide (NO) Modulation: BPC-157 interacts with the nitric oxide system, helping regulate blood pressure and vascular tone during systemic inflammation or injury.
* The Clinical Caveat: Nearly all formal published data is in preclinical animal and cellular models. Despite widespread real-world use and exceptional anecdotal reports, large-scale published human clinical trials are still limited. The Bottom Line: BPC-157 solo is fantastic, but for recovery from injuries or joint wear, the GLOW combo (BPC-157 + TB-500 + GHK-Cu) is the gold standard 3-in-1 stack TB-500 drives rapid cellular migration while GHK-Cu dramatically amplifies collagen synthesis. If your focus is primarily gut healing, the KLOW combo (GLOW + KPV) is even better because KPV targets gut-specific inflammation.

STUDIES

Human studies (small and uncontrolled)

• Knee pain: Lee and Padgett, Alternative Therapies in Health and Medicine 2021. A look back at patient records after BPC-157 injections into the knee; 7 of 12 patients reported improvement lasting more than 6 months. Paper (PDF)
• Interstitial cystitis: Lee, Walker and Ayadi, same journal, 2024. 12 women given a single treatment; 10 reported their symptoms resolved and none reported side effects. There was no comparison group. UroToday abstract
• Phase I safety trial: run in healthy volunteers, but the results were never published.

A 2025 systematic review in HSS Journal rated the human evidence in the lowest quality tiers and found no human safety data. PMC12313605

Using these on posters and posts

• Keep the “studied in rats”, “cell study” and “uncontrolled” labels. Cutting them turns a research summary into a health claim, which is the line that matters under UK medicines rules and for Meta.
• Present the human studies as early pilot data, not proof. The interstitial cystitis result in particular sounds dramatic, but it’s 12 patients with no comparison group.
• Say where the research comes from. “Most studies come from one Croatian group; independent work from Taiwan supports some findings” makes you look more credible, not less.

Sources: - All links.

• PubMed 14554208 – Achilles tendon, 2003
• PubMed 20225319 – Ligament healing, 2010
• PubMed 20190676 – Muscle healing, 2010
• PMC6271067 – Tendon fibroblasts, 2014
• PubMed 27847966 – VEGFR2 angiogenesis, 2017
• PubMed 32445447 – NSAID gut protection, 2020
• CROSBI – Tudor et al. 2010, brain injury
• Knee pain study, 2021 (PDF)
• Interstitial cystitis pilot, 2024 – UroToday
• Vasireddi et al., HSS Journal 2025 – systematic review
• Wikipedia – BPC-157

Lyophilised powder